Orders | Qty | Bid |
---|---|---|
0 | 0 | 0 |
0 | 0 | 0 |
0 | 0 | 0 |
0 | 0 | 0 |
0 | 0 | 0 |
Ask | Qty | Orders |
---|---|---|
1403.4 | 1 | 113 |
0 | 0 | 0 |
0 | 0 | 0 |
0 | 0 | 0 |
0 | 0 | 0 |
Acutaas Chemicals Limited (formerly Ami Organics Limited) is a leading Indian specialty and pharmaceutical chemical manufacturer headquartered in Surat, Gujarat. Established originally as a partnership firm in 2004 and reconstituted in 2007 as a private limited company, it has steadily evolved into a listed entity, achieving several milestones along the way.
The company’s product portfolio spans pharmaceutical intermediates, specialty and fine chemicals, battery chemicals, and semiconductor-grade products, serving more than 600 customers across approximately 55 countries. With four multipurpose manufacturing facilities located in Sachin, Ankleshwar, Jhagadia (Gujarat), and Greater Noida (Uttar Pradesh), Acutaas has developed advanced capabilities in high-purity production, automation, and process safety.
Notably, it is the first company in India outside China to develop global electrolyte additives for batteries and remains the only Indian manufacturer of semiconductor-grade photoresist chemicals.
Its strong R&D foundation, 610+ commercialised products, and 22+ patents granted or filed have positioned it as a trusted partner for global industries.
Key milestones include acquisitions of units from Gujarat Organics and Baba Fine Chemicals, IPO listing on BSE and NSE, USFDA and PMDA approvals, and its rebranding to Acutaas Chemicals Limited in 2025 to reflect sharper focus on innovation-driven specialty solutions.
Acutaas operates across four major verticals:
In FY2025, exports contributed 74% of revenues, largely from Europe (63%), while India accounted for 26%
The company caters to pharmaceuticals, semiconductors, battery technologies, agrochemicals, personal care, and other specialty sectors.
Acutaas operates four sites—Sachin, Ankleshwar, and Jhagadia in Gujarat, and Greater Noida in Uttar Pradesh.
Exports contributed 74% of revenue in FY2025, with Europe being the largest market.